QPCT produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 339 amino acids (29-361a.a.) and having a molecular mass of 38.7kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa). QPCT is expressed with a 6 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.
Glutaminyl-Peptide Cyclotransferase (QPCT) is an enzyme that plays a crucial role in the post-translational modification of proteins. It catalyzes the conversion of N-terminal glutaminyl residues into pyroglutamyl residues, a modification that is essential for the stability and function of various peptide hormones and neuropeptides. This enzyme is particularly significant in the pituitary and adrenal glands, where it is involved in the generation of N-terminal pyroglutamyl groups of peptide hormones such as neurotensin and thyrotropin-releasing hormone .
Recombinant human QPCT is a form of the enzyme that is produced using recombinant DNA technology. This involves inserting the gene that encodes QPCT into a suitable host cell, such as the insect cell line Spodoptera frugiperda (Sf21), which is then cultured to produce the enzyme. The recombinant enzyme is typically tagged with a histidine tag to facilitate purification and is supplied in a carrier-free form to avoid interference from other proteins .
The preparation of recombinant human QPCT involves several steps:
The activity of recombinant human QPCT is measured by its ability to convert glutaminyl-AMC (a synthetic substrate) to pyroglutamyl-AMC. The specific activity of the enzyme is greater than 550 pmol/min/μg under the described conditions . This enzymatic activity is crucial for the formation of stable and functional peptide hormones and neuropeptides.
Recombinant human QPCT is used in various research applications, including: